Clinical Research in Cardiology

, Volume 95, Issue 7, pp 379–382 | Cite as

Use of heparin upon reoperation in a pediatric patient with heparin-induced thrombocytopenia after disappearance of antibodies

  • Christian Schreiber
  • W. Dietrich
  • S. Braun
  • M. Kostolny
  • A. Eicken
  • R. Lange
CLINICAL CORRESPONDENCE

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Klenner AF, Lubenow N, Raschke R, Greinacher A (2004) Heparin–induced thrombocytopenia in children: 12 new cases and review of the literature. Thromb Haemost 91:719–724PubMedGoogle Scholar
  2. 2.
    Kojori F, Chen R, Caldarone CA, Merklinger SL, Azakie A, Williams WG, Van Arsdell GS, Coles J, McCrindle BW (2004) Outcomes of mitral valve replacement in children: a competing– risks analysis. J Thorac Cardiovasc Surg 128:703–709PubMedCrossRefGoogle Scholar
  3. 3.
    Koster A, Meyer O, Fischer T, Kukucka M, Krabatsch T, Bauer M, Kuppe H, Hetzer R (2001) One–year experience with the platelet glycoprotein IIb/IIIa antagonist tirofiban and heparin during cardiopulmonary bypass in patients with heparin–induced thrombocytopenia type II. J Thorac Cardiovasc Surg 122:1254–1255PubMedCrossRefGoogle Scholar
  4. 4.
    Laubenthal FC, Grosch B, Szurawitzki G, Sabin GV (1999) Heparin–induced thrombocytopenia type II with early aortocoronary bypass occlusion and stent thrombosis after PTCA of the RCA – treatment with lepirudin (Refludan) and abciximab (Reo pro) during recanalization of the RCA. Z Kardiol 88:141–146PubMedCrossRefGoogle Scholar
  5. 5.
    Meyer O, Salama A, Pittet N, Schwind P (1999) Rapid detection of heparininduced platelet antibodies with particle gel immunoassay (ID–HPF4). Lancet 354:1525–1526PubMedCrossRefGoogle Scholar
  6. 6.
    Nand S, Wong W, Yuen B, Yetter A, Schmulbach E, Gross Fisher S (1997) Heparin–induced thrombocytopenia with thrombosis: incidence, analysis of risk factors, and clinical outcomes in 108 consecutive patients treated at a single institution. Am J Hematol 56:12–16PubMedCrossRefGoogle Scholar
  7. 7.
    Pötzsch B, Klovekorn WP, Madlener K (2000) Use of heparin during cardiopulmonary bypass in patients with a history of heparin–induced thrombocytopenia. N Engl J Med 343:515PubMedCrossRefGoogle Scholar
  8. 8.
    Risch L, Huber AR, Schmugge M (2005) Diagnosis and treatment of heparin–induced thrombocytopenia in neonates and children. Thrombosis Research (in press, available online 9 February 2005)Google Scholar
  9. 9.
    Warkentin TE, Levine MN, Hirsh J, Horsewood P, Roberts RS, Gent M, Kelton JG (1995) Heparin–induced thrombocytopenia in patients treated with low–molecular–weight heparin or unfractionated heparin. N Engl J Med 332:1330–1335PubMedCrossRefGoogle Scholar
  10. 10.
    Warkentin TE, Kelton JG (1996) A 14–year study of heparin–induced thrombocytopenia. Am J Med 101:502–507PubMedCrossRefGoogle Scholar
  11. 11.
    Warkentin TE, Greinacher A (2003) Heparin–induced thrombocytopenia and cardiac surgery. Ann Thorac Surg 76:2121–2131PubMedCrossRefGoogle Scholar

Copyright information

© Steinkopff-Verlag 2006

Authors and Affiliations

  • Christian Schreiber
    • 1
  • W. Dietrich
    • 2
  • S. Braun
    • 3
  • M. Kostolny
    • 1
  • A. Eicken
    • 4
  • R. Lange
    • 1
  1. 1.Deutsches Herzzentrum MünchenKlinik für Herz-Gefäßchirurgie an der Technischen Universität MünchenMünchenGermany
  2. 2.Department of AnaesthesiologyDeutsches Herzzentrum MünchenMünchenGermany
  3. 3.Department of Laboratory MedicineDeutsches Herzzentrum MünchenMünchenGermany
  4. 4.Department of Paediatric Cardiology and Congenital Heart DiseaseGerman Heart Center Munich at the Technical University MunichMunichGermany

Personalised recommendations